Bristol-Myers, Five Prime expand work on cancer, other drugs
Drugmaker Bristol-Myers Squibb Co. is expanding its collaboration with Five Prime Therapeutics Inc., which could receive more than $1.75 billion if they succeed in turning Five Prime's antibody-based drug candidates into ...
Oct 15, 2015
0
11